Health and Healthcare
Supreme Court Justices Unanimous on Denying Patents for Human Genes
Published:
Last Updated:
The case was brought by cancer patients and others who challenged a patent issued to Myriad Genetics Inc. (NASDAQ: MYGN) on two human genes that are used to indicate increased risk for developing breast cancer or ovarian cancer in women. Myriad’s patents allowed the company to be the sole U.S. provider of genetic tests for the cancers.
Today’s ruling, written by Justice Thomas, said that isolated DNA is a “product of nature and not patent eligible merely because it has been isolated.” However cDNA molecules, which are only the part of human genes that are able to encode proteins, may be patentable.
The ruling was seen as a partial victory for Myriad, and the company’s shares are up 10.3% at $37.44, after posting a new 52-week high of $38.47 earlier. The 52-week low is $22.02.
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
